Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Shareholders' Equity

v3.22.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive (Loss) Gain
Beginning balance at Mar. 31, 2019 $ 974,400 $ 200 $ 230,000 $ 197,600 $ 577,100 $ 200 $ (30,300)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 241,500       241,500    
Other comprehensive gain (loss) (31,800)           (31,800)
Stock-based compensation 10,300   600 9,700      
Dividends declared (159,300)       (159,300)    
Ending balance at Mar. 31, 2020 1,035,300   230,600 207,300 659,500   (62,100)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 262,800       262,800    
Other comprehensive gain (loss) 55,500           55,500
Stock-based compensation 18,000   800 17,200      
Issuance of ordinary shares 100     100      
Dividends declared (310,900)       (310,900)    
Ending balance at Mar. 31, 2021 1,060,800   231,400 224,600 611,400   (6,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 459,100       459,100    
Other comprehensive gain (loss) (15,400)           (15,400)
Stock-based compensation 6,200   700 5,500      
Issuance of ordinary shares 300     300      
Dividends declared (178,100)       (178,100)    
Ending balance at Mar. 31, 2022 $ 1,332,900   $ 232,100 $ 230,400 $ 892,400   $ (22,000)